Replies to post #9825 on Momenta Pharmaceuticals, Inc. (MNTA)

[pollyvonwog]

Roger on final. I do think MNTA/Sandoz/MYL have a solid shot of defeating that 2015 patent in appeals though, but that's another story.

With regards to Mylan's powerhouse status, I'll again refer to TEVA whom has yet (and probably never will) to get t-enox (also a knock-off, like Mylan's) approved so it's not that simple.

And I still contend that if MNTA gets m-copax approved (as I imagine it will be done in similar way to m-enox, where MNTA pretty much made the rules), it will be a telling statement from the FDA on how they'll respond to MNTAs FOB program (Which I know you attribute 0 value).